Recombinant DNA vaccines (Vical/NIAID)

N/A

Report date: 2022/11/27 13:48:53

Base Information

Drug NameRecombinant DNA vaccines (Vical/NIAID)
Drug Alias Name重组DNA疫苗-Vical/NIAIDVRC-WNVDNA020-00-VPVRC-WNVDNA017-00-VP
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsWest Nile Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Fresh Tracks Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFresh Tracks Therapeutics IncNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsWest Nile Fever

Other Information

ATC CodeN/A
Related LinksN/A